Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically significant and clinically meaningful improvement in prosta ...

Investigators found no evidence that management consulting firms improved finances, operations, or quality of care at nonprofit hospitals.

(Palvella or "the Company") (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin ...

The latest Fraud and Error in the Benefit System report estimates 3.2 per cent of benefit spending was overpaid in the ...

Summary: A Phase 2 randomized clinical trial demonstrates that a single 25 mg dose of psilocybin, combined with psychotherapeutic support, provides rapid, statistically significant, and clinically ...

The Department for Work and Pensions (DWP) has published new figures ...

Regenxbio announces positive results from pivotal phase III AFFINITY DUCHENNE study of RGX-202 to treat Duchenne muscular dystrophy: Rockville, Maryland Friday, May 15, 2026, 14:0 ...

The Department for Work and Pensions (DWP) has published new figures ...

New fraud and error figures show changes in claimants’ health and daily living needs accounted for most incorrect PIP ...

Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...

Progress has also slowed in reducing the risk of death from noninfectious diseases like cancer, diabetes and cardiovascular ...

As van and flatbed volumes surge and rejection rates climb, the very conditions driving optimism are making it increasingly ...